利福平与异烟肼治疗皮肤利什曼病的疗效
Efficacy of rifampicin and isoniazid in cutaneous leishmaniasis.
作者信息
Livshin R, Weinrauch L, Even-Paz Z, el-On J
出版信息
Int J Dermatol. 1987 Jan-Feb;26(1):55-9. doi: 10.1111/j.1365-4362.1987.tb04578.x.
Abstract
Thirty-nine patients with cutaneous leishmaniasis caused by Leishmania major were treated with rifampicin alone or in combination with isoniazid. No significant difference was found between these two therapeutic regimens, and about half of the patients were cured 2 months from the beginning of treatment. A review of rifampicin in cutaneous leishmaniasis is attached.
摘要
39例由硕大利什曼原虫引起的皮肤利什曼病患者接受了单独使用利福平或联合异烟肼的治疗。这两种治疗方案之间未发现显著差异，约一半的患者在治疗开始2个月后治愈。本文附上了一篇关于利福平治疗皮肤利什曼病的综述。
Zotero 插件